Clinical Trial Update: Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium

View source ↗

Summary

Observational study evaluating effectiveness of paritaprevir/ritonavir-ombitasvir ± dasabuvir ± ribavirin in chronic hepatitis C genotypes 1 or 4; completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Dasabuvir (dasabuvir)
• Ribavirin (ribavirin)
• paritaprevir/ritonavir-ombitasvir (paritaprevir/ritonavir-ombitasvir)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C, Genotype 1 or 4 | Status: COMPLETED | Results posted: 2019-05-06